Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Parent-determined Oral Montelukast Therapy for Preschool Wheeze With Stratification for Arachidonate-5-Lipoxygenase (ALOX5) Promoter Genotype

NCT01142505 is registered in ClinicalTrials.gov with Queen Mary University of London as lead sponsor.

NCT NCT01142505
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01142505 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Parent-determined Oral Montelukast Therapy for Preschool Wheeze With Stratification for Arachidonate-5-Lipoxygenase (ALOX5) Promoter Genotype
Lead sponsor
Queen Mary University of London
Phase
Phase 3
Overall status
Completed
Start date
November 30, 2010
Completion date
February 28, 2014
Enrollment
1,358 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

wheezing